bioMérieux S.A.

€93.30As of Sun 8 Nov 2026, 12:00 UTC
EPA:BIMHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 8.49%
Div yield 1.05%
ROE 11.22%
Diagnostics & Research
Beta (5Y) 0.59
PE TTM 23.92
TSR TTM (15.25%)
Mkt cap €10.98B
ROIC 11.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€114
22.37%
(59.97%)
Hold 6|1|10|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share€
1.07
1.16
1.16
1.22
(6.07%)
6.44%
10.27%
13.08%
Revenue€M
581.6
585.1
573.6
592.3
9.77%
4.25%
0.23%
2.13%
Peers (US$12.33B)
Cap (US$)
PE
24.67B
67.80x
14.61B
25.72x
11.40B
53.14x
Capital
TTM
5Y
10Y
Leveragex
1.553
(0.120)
(0.109)
EBIT/Intx
1.362
0.131
0.117
Own earn%
(90.24)
183.09
143.64
Sh yield%
37.10
33.94
34.14
Owners
Insiders/Inst%
0.39
75.57
Short interest%
0.95
SBC / revenue%
2.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
20–25
$1 testx
—
Incr. ROIC%
15